These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 36859773)

  • 1. Human antibody V
    Chu X; Li W; Hines MG; Lyakhov I; Mellors JW; Dimitrov DS
    Front Oncol; 2023; 13():1194972. PubMed ID: 37876962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemically Administered Anti-uPAR Antibody Plasma and Lung ELF Pharmacokinetics Characterized by Minimal Lung PBPK Model.
    Sharma S; Leonard A; Phoenix K; Chang HY; Wang J; Hansel S
    AAPS PharmSciTech; 2023 Nov; 24(8):236. PubMed ID: 37989972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interface-driven structural evolution on diltiazem as novel uPAR inhibitors: from in silico design to in vitro evaluation.
    Xie S; Zhou Y; Zhu H; Xu X; Zhang H; Yuan C; Huang M; Xu P; Li J; Liu Y
    Mol Divers; 2024 Jun; ():. PubMed ID: 38935305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cadonilimab, a tetravalent PD-1/CTLA-4 bispecific antibody with trans-binding and enhanced target binding avidity.
    Pang X; Huang Z; Zhong T; Zhang P; Wang ZM; Xia M; Li B
    MAbs; 2023; 15(1):2180794. PubMed ID: 36872527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mechanism of tumor cell-induced extracellular matrix degradation--inhibition of cell-surface proteolytic activity might have a therapeutic effect on tumor cell invasion and metastasis].
    Kobayashi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):623-32. PubMed ID: 8808830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-throughput optofluidic screening of single B cells identifies novel cross-reactive antibodies as inhibitors of uPAR with antibody-dependent effector functions.
    Lourenço AL; Chuo SW; Bohn MF; Hann B; Khan S; Yevalekar N; Patel N; Yang T; Xu L; Lv D; Drakas R; Lively S; Craik CS
    MAbs; 2023; 15(1):2184197. PubMed ID: 36859773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting uPAR with antagonistic recombinant human antibodies in aggressive breast cancer.
    LeBeau AM; Duriseti S; Murphy ST; Pepin F; Hann B; Gray JW; VanBrocklin HF; Craik CS
    Cancer Res; 2013 Apr; 73(7):2070-81. PubMed ID: 23400595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.
    Duriseti S; Goetz DH; Hostetter DR; LeBeau AM; Wei Y; Craik CS
    J Biol Chem; 2010 Aug; 285(35):26878-26888. PubMed ID: 20501655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T; Behrendt N; Ploug M
    Stem Cells; 1997; 15(6):398-408. PubMed ID: 9402652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice.
    Jo M; Takimoto S; Montel V; Gonias SL
    Am J Pathol; 2009 Jul; 175(1):190-200. PubMed ID: 19497996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A covalent inhibitor of K-Ras(G12C) induces MHC class I presentation of haptenated peptide neoepitopes targetable by immunotherapy.
    Zhang Z; Rohweder PJ; Ongpipattanakul C; Basu K; Bohn MF; Dugan EJ; Steri V; Hann B; Shokat KM; Craik CS
    Cancer Cell; 2022 Sep; 40(9):1060-1069.e7. PubMed ID: 36099883
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Search and sequence analysis tools services from EMBL-EBI in 2022.
    Madeira F; Pearce M; Tivey ARN; Basutkar P; Lee J; Edbali O; Madhusoodanan N; Kolesnikov A; Lopez R
    Nucleic Acids Res; 2022 Jul; 50(W1):W276-W279. PubMed ID: 35412617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single B cell technologies for monoclonal antibody discovery.
    Pedrioli A; Oxenius A
    Trends Immunol; 2021 Dec; 42(12):1143-1158. PubMed ID: 34743921
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.